FeesSafety
Pluang+

Pulmatrix expects to complete merger with Eos SENOLYTIX by end of 2026, advancing its biopharma pipeline.

Company Fundamentals
17 Nov 2026, 15:05 WIB
PRNewsWire
View Source
Bullish
Pulmatrix expects to complete merger with Eos SENOLYTIX by end of 2026, advancing its biopharma pipeline.

Pulmatrix, a biopharmaceutical company, announced it expects to close its merger with Eos SENOLYTIX by the end of 2026 after receiving SEC and stockholder approvals. The merger will combine Pulmatrix's inhaled therapeutic products with Eos's gerotherapeutic peptide platform targeting aging-related diseases. Pulmatrix is also seeking to license or monetize its clinical assets, including its iSPERSE™ technology and drug candidates PUR1900, PUR3100, and PUR1800. Financially, Pulmatrix reported increased administrative expenses due to merger activities and holds $1.4 million in cash as of September 2026, sufficient to fund operations through the merger closing.

Pulmatrix's merger news provides context for readers following health sector stocks. For readers following health stocks, here is Pluang's market snapshot as of Nov 17, 2026 20:04 WIB: Out of 150 priced health-sector US stocks, 49 rose and 91 fell. Guardant Health Inc. (GH) rose 2.05% to USD 146.98 with a typical hold time of 10 days. Elevance Health Inc. (ELV) fell 1.86% to USD 438.00 with a typical hold time of 13 days. Aveanna Healthcare Holdings Inc. (AVAH) rose 1.81% to USD 11.84 with a typical hold time of 13 days.

More News

Adagene and City of Hope launch Phase 1 trial for new colorectal cancer combo therapy.

Adagene and City of Hope launch Phase 1 trial for new colorectal cancer combo therapy.

Adagene Inc. and City of Hope have started a Phase 1 clinical trial testing a new combination therapy for metastatic colorectal cancer patients resistant to standard treatments. The trial evaluates two experimental drugs, ivonescimab and muzastotug (...

Others
Bullish
58 minutes ago
Provident Bank appoints three leaders to boost commercial banking growth and services.

Provident Bank appoints three leaders to boost commercial banking growth and services.

Provident Bank announced three key leadership appointments to strengthen its Commercial Banking division. Edward Galan will lead Middle Market Lending, Dawn Scocco will manage portfolio and credit risk, and John Maio will head Treasury Management Ser...

Market News
Bullish
58 minutes ago
RoyaLand launches its first mobile game Palazzo Chronicles: Match 3 on Google Play.

RoyaLand launches its first mobile game Palazzo Chronicles: Match 3 on Google Play.

RoyaLand Company Ltd. has released its first mobile game, Palazzo Chronicles: Match 3, on the Google Play Store. The free-to-play match-3 puzzle game features over 270 levels where players restore a royal palace set in Risorgimento Italy. This launch...

Others
Bullish
58 minutes ago
Atiq Khan joins Dune as Director of Engineering to lead real-time onchain market data development.

Atiq Khan joins Dune as Director of Engineering to lead real-time onchain market data development.

Atiq Khan, with over 25 years in financial technology including roles at Goldman Sachs and Coinbase, has joined Dune as Director of Engineering. He will lead the engineering efforts behind Dune Market Data Feeds, which provide real-time trade and liq...

Others
Bullish
58 minutes ago
BlackRock increases voting rights in ICG PLC to 5.16% as of November 13, 2026

BlackRock increases voting rights in ICG PLC to 5.16% as of November 13, 2026

BlackRock, Inc. has increased its total voting rights in ICG PLC to 5.16% as of November 13, 2026, up from 5.17% previously reported. This includes 5.08% voting rights attached to shares and 0.08% through financial instruments. The notification was o...

Market News
Neutral
58 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App